Pacira (PCRX) announced it has acquired the remaining 81% equity stake of GQ Bio Therapeutics for approximately $32M, net of working capital ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...

Q4 2024 Earnings Call Transcript February 26, 2025 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $ ...

The Board of Foresight Technology VCT plc is pleased to announce that at the General Meeting of the Company held on 26 ...

City University of Seattle (CityU)?a private, nonprofit leader in serving nontraditional, working, military students and offering diverse global study opportunities?today announced the appointment of ...

If your group or agency has changed or canceled an event, write to [email protected] or leave a message at 737-5042. Events Tehama County Food Share needs shelf-stable milk (powder or boxed ...

PARSIPPANY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...